Monday, 28 September 2026Updated 12m ago
← Top stories
Policy● Neutral for Indian equities

CDSCO steps up scrutiny of pharma drugs containing narcotic substances

1 source · first seen 00:41 28 Sept · updated 00:41 28 Sept

The brief

Written from 1 report · check the source before you trade
  • CDSCO is addressing regulatory gaps around illegal diversion of pharmaceutical drugs containing narcotic substances
  • Tighter scrutiny may raise compliance risks for Indian pharma manufacturers handling narcotic medicines

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare20 today

Linked by the tag Pharma and healthcare

62 stories this week
  1. 27 SeptFortis says independent audit will establish non-involvement in Singh brothers’ share transfersLegal · 2 sources · Supreme Court cleared the way for an independent forensic audit of the share transfers
  2. 27 SeptFortis confident of clean chit from audit in Singh brothers’ disputeLegal · 1 source · Fortis expects a clean chit from the audit in the Singh brothers’ dispute
  3. 25 SeptSupreme Court allows independent forensic audit of Fortis transactions in Daiichi disputeLegal · 6 sources · The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
  4. 25 SeptRegulator mulls digital platform for drugmakers' test reportsPolicy · 1 source · India’s drug regulator is developing a digital platform for consumers to view batch-level quality-test reports
  5. 24 SeptMint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registryPolicy · 1 source · NHRC wants the drugs regulator to build a national digital registry using QR codes and drug-tracking tools
All Pharma and healthcare stories →

Read the reports

1 report · earliest 00:41
Economic TimesCDSCO steps up scrutiny of pharma drugs containing narcotic substances00:41